Vildagliptin (Galvus) for type 2 diabetes
Published in Medicine Update
Date published: About this date
This Medicine Update is for people who have been prescribed vildagliptin.
Vildagliptin (brand name Galvus) is a new medicine. It is a tablet that can be used by people with type 2 diabetes whose blood glucose cannot be controlled effectively with certain other medicines.
If you are prescribed vildagliptin, you will take it in addition to your existing diabetes medicine. Vildagliptin, taken with your other medicine, can help better control blood glucose. Controlling blood glucose is important if you are to avoid the long-term complications of diabetes.
Vildagliptin has been through the required clinical trials and is effective in helping to lower blood glucose. But because it is a new medicine, it is not yet known if it reduces the long-term complications of diabetes.
- What vildagliptin is
- What vildagliptin is for
- Who can take vildagliptin
- How to take vildagliptin
- What does vildagliptin do?
- Important side effects of vildagliptin to consider
- What else you should know about vildagliptin
- Other medicines available for type 2 diabetes
- How to decide between vildagliptin and other medicines
- What does vildagliptin cost?
- Other ways to help type 2 diabetes
- Where to find more information.
The active ingredient of this medicine is vildagliptin (pronounced VIL-da-GLIP-tin). It is also known by the brand name Galvus.
Vildagliptin is a medicine for type 2 diabetes.
Vildagliptin treats type 2 diabetes.
People with type 2 diabetes have too much glucose (sugar) in their blood because their body does not produce enough insulin or their insulin has become less effective (called insulin resistance).
Having high blood glucose levels increases your risk of developing the long-term complications of diabetes.
These complications are serious. People with diabetes may develop heart disease, kidney disease, eye disease, pain or loss of feeling and poor circulation in the feet, and problems with sexual function.
Vildagliptin treats type 2 diabetes by controlling blood glucose levels.
Vildagliptin is available on the Pharmaceutical Benefits Scheme (PBS) for people with type 2 diabetes, but there are some restrictions on its use. In general terms, you can get vildagliptin through the PBS if:
- you are already taking metformin (e.g. Diabex, Diaformin) or a sulfonylurea (e.g. Amaryl, Daonil, Diamicron, Minidiab), and
- your HbA1c (a measurement that reflects your average blood glucose levels over the last 10–12 weeks) is over 7%, and
- you cannot use a combination of metformin and a sulfonylurea, or the combination causes you intolerable side effects.
Please note — vildagliptin is not taken on its own. You will need to continue taking your metformin or sulfonylurea when you start vildagliptin.
Speak to your doctor if you have liver or kidney problems. Vildagliptin is not suitable for people with liver problems. Your doctor will have to take into account any kidney problems you have before prescribing vildagliptin.
Your doctor will tell you to take either one or two tablets each day. If you take one tablet, you should take it in the morning. If you take two tablets, take one tablet in the morning and the other tablet in the evening.
You can take vildagliptin tablets with or without food. Swallow the tablets whole with a glass of water.
It’s important that you take the right number of vildagliptin tablets each day. Ask your doctor if you are not sure whether you should be taking one or two tablets.
Vildagliptin reduces glucose levels in the blood. It does this by:
- increasing the amount of insulin in the blood
- reducing the amount of glucose produced by the liver.
It is not yet known if vildagliptin reduces the long-term complications of diabetes (see How to decide between vildagliptin and other medicines).
Ask your health professional about the possible side effects of this medicine before you take it. Always tell them about any changes to your condition if you're taking a new medicine.
To report possible side effects call the NPS Adverse Medicine Events (AME) Line on 1300 134 237 from anywhere in Australia (Monday–Friday, 9am–5pm AEST).
People with questions about their medicines or seeking general information about side effects can call the NPS Medicines Line on 1300 633 424 (Monday–Friday, 9am–5pm AEST).
The most common side effects of vildagliptin are headache and cold-like symptoms.
Some rare but serious side effects can occur with vildagliptin , such as:
- allergic reactions
- pancreatitis (inflammation of the pancreas that can result in severe, long-lasting abdominal pain).
Allergic reactions are rare, but you should seek medical attention if you have any swelling of the face, mouth, tongue or throat.
Pancreatitis has developed in a few people after starting vildagliptin. But it’s not known for sure if vildagliptin caused the pancreatitis.
Vildagliptin has been tested in clinical trials, but it is a new medicine so the full range of side effects is not yet known. You should be aware of this and talk to your doctor if you have any concerns.
For a more complete list of possible side effects for Galvus (vildagliptin), see the consumer medicine information (CMI) leaflet available on our Medicines Finder page.
Some other medicines can interact with vildagliptin.
You should tell your doctor about all the medicines you take, including any you get from a pharmacy, supermarket or health food store.
Vildagliptin tablets contain lactose — you should talk to your doctor if you are lactose intolerant.
Use a medicines list to help keep track of the medicines you are taking. Take it with you each time you visit a health professional, or if you go into hospital.
Most people start taking medicines when lifestyle changes, diet and exercise are not sufficient to manage their diabetes.
Your medicine options will depend on your blood glucose control, your response (including side effects), your age and health, and other medicines that you are taking.
The medicines you take for your diabetes may change over time. For example, you might only need a single tablet — like metformin or a sulfonylurea — to control your blood glucose initially. But diabetes tends to get worse as you get older, and at some point your doctor may recommend that you take more than one type of tablet, or that you take insulin, or a combination of tablets and insulin. Each medicine will work in a different way to control your blood glucose level.
The other types of medicine you might take are:
- acarbose and repaglinide.
Sitagliptin (Januvia) is another medicine you may be asked to consider. It belongs to the same group of medicines as vildagliptin.
See the NPS Medicine Update for sitagliptin.
Metformin (e.g. Diabex, Diaformin) is the first tablet most people take for type 2 diabetes. It makes your own insulin more effective and reduces the amount of glucose produced by your liver.
Metformin may cause nausea, loss of appetite and diarrhoea.
Sulfonylureas are often added to metformin. They may also be used as the first tablet by people who cannot take metformin. Sulfonylureas increase your body’s production of insulin.
The sulfonylureas include glibenclamide (e.g. Daonil), gliclazide (e.g. Diamicron), glimepiride (e.g. Amaryl, Dimirel) and glipizide (e.g. Minidiab).
Many people taking sulfonylureas gain weight and may have hypoglycaemic episodes (when blood glucose drops below normal levels). Allergic reactions may occur.
Pioglitazone (Actos) and rosiglitazone (Avandia) are relatively new medicines for type 2 diabetes. Like vildagliptin, pioglitazone and rosiglitazone can be taken with metformin or a sulfonylurea. Glitazones make your own insulin more effective.
Glitazones can cause fluid retention and weight gain, and increase the risk of some bone fractures in women.
Glitazones are not suitable for people with heart failure. Rosiglitazone should not be used by people with heart disease.
Exenatide (Byetta) is a new injectable medicine, but it is not insulin. It is used in addition to tablets to help reduce blood glucose levels.
Some people feel nauseous when they start using exenatide. People using exenatide can have hypoglycaemic episodes, particularly if they are also taking a sulfonylurea.
See the NPS Medicine Update for exenatide.
If you can no longer make enough of your own insulin, tablets such as metformin and sulfonylureas will not work properly. At this point your doctor might suggest that you start using insulin to control your blood glucose level.
Insulin can be used on its own or with some other medicines for type 2 diabetes. Vildagliptin is not usually used with insulin.
Insulin is injected — usually once, twice or three times a day. While many people worry about injecting insulin, most find the injections are not painful.
The main side effects of insulin are weight gain and hypoglycaemia. Allergic reactions are possible and some people get skin reactions at the site of injections.
See the section on insulin in the NPS knowledge hub on type 2 diabetes.
Acarbose and repaglinide
Acarbose (Glucobay) and repaglinide (Novonorm) are used by a small number of people for whom other medicines are unsuitable.
There are two main reasons to treat your diabetes:
- to keep your blood glucose levels down
- to reduce your risk of developing the complications of diabetes.
Like all medicines used for type 2 diabetes, vildagliptin reduces the level of glucose in the blood.
But it is not known if it can reduce your risk of developing the complications of diabetes. This will only become clear when vildagliptin has been used by more people for longer periods of time.
Insulin, metformin and sulfonylureas have been shown to reduce the complications of diabetes. This is a very important benefit of these medicines.
Weight gain and hypoglycaemia
Most medicines for type 2 diabetes — except metformin— can sometimes cause hypoglycaemia. Hypoglycaemia is more likely with insulin than with tablets, and is more likely with sulfonylureas than with other tablets.
Vildagliptin does not appear to increase the risk of hypoglycaemia when taken with metformin. Nor does it cause weight gain. However, hypoglycaemia and weight gain may still occur if vildagliptin is used with a sulfonylurea.
Most medicines prescribed by your doctor are covered by the Pharmaceutical Benefits Scheme (PBS). This means that the Australian Government pays most of the cost of your medicine. For more information see www.pbs.gov.au.
Cost to the Government
The full cost of vildagliptin is as follows:
- $97.24 for 50 mg vildagliptin tablets (pack size 60 tablets)
Cost to the individual
If you get vildagliptin through the PBS, the Australian Government pays most of the cost and you will pay only a part, called the co-payment.
At the time of publication, the co-payment for people who are entitled to get vildagliptin through the PBS was:
- $33.30 for people without a concession card
- $5.40 for concession card holders.
Each prescription lasts 30 days or 60 days, and you can get up to 5 repeats.
If you are not eligible to get vildagliptin through the PBS, you will need to pay the full price for a prescription.
Other ways to help type 2 diabetes
A healthy, balanced diet is important for all people with diabetes. A dietitian, diabetes educator or doctor can help you with this.
Regular physical activity is important for managing diabetes. Many people find that their diabetes is easier to manage with regular physical activity (e.g. 30 minutes of physical activity on five or more days per week). Resistance training (e.g. using light weights) is recommended, as is aerobic exercise (e.g. walking or cycling). A diabetes educator, exercise physiologist or doctor can help you with this.
If you have just been diagnosed with type 2 diabetes, your doctor will usually recommend that you eat a healthy, balanced diet and exercise regularly for three months to see if this controls your diabetes without the need for medication (unless the symptoms of diabetes are severe).
Even when using medicines, you should continue to follow a healthy, balanced diet and carry out regular exercise. This can help you to maintain a healthy weight. It may also improve your blood glucose control, reduce your need for medicines and help to prevent some of the long-term complications of diabetes.
Testing your glucose
Testing your own blood glucose levels regularly can help you to manage your diabetes. Speak to your diabetes educator or doctor.
If you smoke, you should make every effort to quit. The combination of smoking and diabetes greatly increases the risk of heart disease and other complications of diabetes. Quitting smoking will also have a positive impact on your health and substantially reduce your risk of other illnesses. For more information, contact the Quitline on 13 QUIT (13 7848) or get an online quitting coach from www.quitcoach.org.au.
If you drink alcohol, then a low-to-moderate intake is best. You should discuss this with your health professional. Alcohol can interact with some diabetes medicines, and make hypoglycaemia more likely.
If you have diabetes and high blood pressure, it’s important that you work with your doctor to keep your blood pressure under control. Studies have shown that good blood pressure control can prevent some of the long-term complications of diabetes.
For more information, contact Diabetes Australia on 1300 136 588 or at www.diabetesaustralia.com.au.
Where to find out more information
You can find more information in the consumer medicine information (CMI). This will tell you:
- who should not use the medicine
- which other medicines should be avoided
- how to take the medicine
- most of the possible side effects
- the ingredients.
You can get the CMI leaflet for Galvus from:
- your doctor or pharmacist
- our Medicines Finder page
- Novartis, the makers of Galvus (vildagliptin), on 1800 671 203.
Information over the phone
NPS works with healthdirect Australia to provide the Medicines Line phone service for consumers.
To get more information about any medicine call 1300 MEDICINE (1300 633 424). This service is available from anywhere in Australia, Monday to Friday, 9am to 5pm AEST excluding NSW public holidays.
To report a side effect
Call the NPS Adverse Medicine Events (AME) Line on 1300 134 237, Monday to Friday, 9am to 5pm AEST excluding public holidays.
The AME Line is a service where you can report possible side effects of your medicine and contribute to national medicine safety efforts. Information on medicine-related side effects is passed on to the Therapeutic Goods Administration (TGA) for assessment, but your personal details will remain confidential and your privacy maintained.
We acknowledge the contribution of the Health Consumers' Council and the other community organisations who provided feedback during the development of this article.